Finance1 min read

The big winners of the tech wreck are biopharma stocks

By · Via MarketWatch Top Stories · Published by Everything Blog

In short

Biopharma stocks have emerged as the primary beneficiaries amid a broader downturn in the technology sector. Shares of major pharmaceutical companies, including Eli Lilly, Gilead, and Johnson & Johnson, continue to reach record highs.

Key points

  • Biopharma stocks have emerged as the primary beneficiaries amid a broader downturn in the…: Biopharma stocks have emerged as the primary beneficiaries amid a broader downturn in the technology sector.
  • Shares of major pharmaceutical companies, including Eli Lilly, Gilead, and Johnson & John…: Shares of major pharmaceutical companies, including Eli Lilly, Gilead, and Johnson & Johnson, continue to reach record highs.

The shares of large drugmakers like Lilly, Gilead and J&J keep hitting record highs.

Finance